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Abstract:
In vivo measurements on Medtronic pacemaker were performed
with a proportional counter for the measurement of neutrons
and with thermoluminescence dosimeters and a scintillation
dose rate meter for gamma measurements. The paper discusses
the technique of phantom cal ibration, the in-vivo measurement
of the neutron emission rate and the estimation of dose
equivalent. Results are presented for phantom and in-vivo
measurement at different positions from the 238pU source.
The dose equivalent rate from neutrons and gamma rays were
measured on seven patients with 238Pu-pacemakers implanted
.and were found to be 5.6 ± 0.1 mrem/h and 2.54 ± 0.5 mrem/h,
respectively at the surface of the pacemaker in 1.25 cm
distance from the center of the source.
Zusammenfassung
Es wurd~n in vive Mes~ungen' an Hedtr6nic Herzschritt~achern
durchgefUhrt, ~ozu ein Propottionalzähle~ zur Me~sung der
Neutronen sowie Thermolumineszenzdosimeter und Szintil lations-
dosis leistungsmesser zur Messung'der Gammastrahlung einge-
setzt wurden. Der Bericht diskutiert die Technik der Phantom~
kaI ibrierung, die in vivo Messung der Neutronenemissionsrate
sowie die Ermittlung der ÄquiValentdosis. Es werden Ergebnisse
von Phantom- und in vive Messungen In verschiedenen Abständen
von d~r 238 Pu -Quelle ~led~rgegeben. Die Äquivalentdosis-
leistung Von Ne~tronen-und Ga~mastrahlu~g wurde ~n 7 Patienten
mit implantierten 238Pu~Herz~ch~ittmacherngemessen und ergab
sich zu 5,6 ± 0,1 mrem/h bzw. 2,54 ± 0,5 mrem/h an der Ober-
fläche des Herzschrittmachers in 1,25 cm Abstand von der
Quellenmitte.
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1. Introduction
The radiation burden from gamma rays and neutrons was measured
on seven patients with 238pU pacemakers implanted. For dose
rate measurement on the very body surface high-sensitive, direct-
reading dose rate meters were used. These are a special kind
of a scinti llation dose rate meter for the gamma measurement
and a large-area proportional counter for the neutron measure-
ment. Special care had to be devoted to the cal ibration of the
detectors placed in this measuring position. Additional measure-
ment runs were required including 238 pU and 252Cf neutron sources
of a known emission rate installed at different distances
(detector-sources) to determine the influence of the body as
we 11 ast he at te nu at ion in t he t iss ue wi t h res p e c t t 0 fission
neutrons and gamma rays. The maximum radiation burden of the
patients on the surface of the pacemaker was found to be a dose
equivalent of 5.6 ± 0.1 mrem/h for neutrons and 2.54 ± 0.5 mrem/h
for ,gamma rays which is in good agreement to the results of other
authors based on free air and phantom measurements.
2. Measurement of Gamma rays
2.1 Dose Rate Measurement
For direct measurement of the gamma dose rate a high-sensitive
scintillqtion dose rate meter Type H 7201 with an indication of
lower than 1 ~R/h was used [lJ allowing to measure the exposure
- 2 -
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rate p ra c t i ca 11yen erg yi nd e pend e n t .i n t he. r an 9 e2 5 keV t 0 1. 2 MeV.
To determine the gamma dose rate on the body sut:"fa<;:e a set of
measurements were performed at distances of Oto 50 cm from the
surface of the patients. The measured dose rate was plotted as
a function of the actual distance source-detector (see for example
Fig.1), taking into account the thickness of tissue (direct measure-
ment on one patient yielded 2cm)~ the distance of the assumed
238pU point source from the surface of the pacemaker (1.25 cm),
the distance of the detector surface from the detector central
po i n t (5 c m), an d t he na tu ra I bac k9 r 0 und rad i a t ion I e v e I. Als 0
in case of the relatively infavorable position on the body sur-
face a square I a w c 0 u ld be f 0 und f 0 r a I I Pa t i e n t s. The a t t e n ua t i on
of gamma rays of 10 ± 1 % at 2 cm tissue depth was obtained by
free air and phantom measurements with a non-implanted pacemaker.
The dose on the surface of the pacemaker implanted was deter-
mined by graphie extrapolation to be 2.54 ± 0.5 mrem/h, taking
into account the square law and the attenuation in the tissue.
2.2 Dose Measurement
For direct measurement of the gamma dose accumulated over a long
time on the body surface of patient G, CaF2:Dy dosimeters of the
size 3 mm x 3 mm x 0.9 mm were exposed for two weeks at 14
positons immediately over the pacemaker. Additional 6LiF and
7LiF dosimeters served to measure thermal neutrons and gamma
rays. The ~esult of this ~eries of measurements is represented
in Fig.2. To record the maximum dose, the dosimeters had been
exposed inan appropriate coordinate system parallel to the X
and Y axes, respectively. The location of the 238pU source and,
hence,of the dose maximum on the body surface could be deter-
mined in the positions 2.4 cm/2.3 cm. The dose rate of the
pacemaker calculated for the body surface from the per iod of
exposure was found to be 0.385 mrem/h with the LiF-dosimeter
and 0.376 mrem/h with the CaF2-dosimeter and was in good
agreement with the measured result of the scintil lation rate
meter, which was 0.380 mrem/h.
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3. Measurement of Neutrons
3.1 Detector Characteristics
Fast neutrons were measured with a large-area proportional counter
of the size 32 cm by 32 cm with butane gas flow in direct contact
with the body surface of the patients. The counter used was a
commercially availabie proportional counter employed in a/ß activity
and contamination measurements. Large-area proportional counters
are able to detect fast neutrons via recoil nuclei generated in
the hydrogenous counter gas as weIl as in the thin detector wal I.
The proportional counter consists of a narrow-meshed counting
wire grid and is operated at high voltage of 2,100 V. In the
absence of a plateau the increase in the counting rate-voltage
characteristic is about 30 % per 100 Volt. The detection
sensitivity of the proportional counter was found to be 7·10- q counts
per neutron for an Am-Se source approximatly in 2n geometry.
The background rate was about 5 cpm. A gamma background level
of 1 R/h from a 60Co source did not change the background rate.
The count rate of the proportional counter was first calibrated
to a neutron emission rate for the given geometry and then
converted into the neutron flux density, taking into account the
square law and the attenuation of the radiation in the body.
3.2 Phantom calibrations
To exa~ine the body influence and the detection characteristics
of the proportional counter, phantom measurements were carried
out at different distances from the source and for tissue-
equivalent plastic layers placed in between. 252Cf and RaD-Be
neutrons sources with higher emission rate were used which in
addition have different effective neutron energies of 2.3 MeV
and 4 MeV, respectively. Under free air condition the proportional
counter coVered with a thin plastic foil of 0.9 mg/cm 2 shows
simi lar proporties with respect to both neutron sources (see
Fig.3). Contrary to free air measurement the proportional
counter shows an increased counting rate for RaD-Be neutrons
compared to 252 Cf neutrons when lower thicknesses are involved
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(see Fig.4). Responsible for this buildup behaviour is a back-
scattering of higher-energetic neutrons in the tissue-equivalent
material.
Additional measurements performed with a 238pU capsule used for
pacemakersshowed that 238 pu emits above all fission neutrons so
that the fraction of higher-energetic (a,n) neutrons has not to
be taken into account for the attenuation in tissue. Table 1
summarizes the counting rate of the proportional counter for
different neutron sources placed at 1.25 cm from the proportional
counter, both for free air measurement and a measurement behind
a tissue layer of 3 cm thickness. The counting rate fractions
resulting from 252Cf and 238 pU neutrons detected at 3 cm tissue
depth differs by less than 10 %. Therefore, for in-vivo
measurements of 238 pU pacemakers cal ibration values were adopted
which had been determined for 252Cf neutrons in Figs.3 and 4.
Neutron detection with the proportional counter is practically
independent of energy for the neutron energy distributions of
interest here, both with respect to the measurement of the neu-
tron emission rate and of the neutron flux density and the dose
equivalent. The pertinent results of cal ibrations are presented
in Table 2. The 2~~Cm source is a plane source, the activity of
which was not sufficiently known. The neutron flux density
measured with the proportional counter differs from the value
calculated from the known emission rate by less than 9 % for
238 pU , 252Cf and RaD-Be. Comparison measurements performed with
a rem-counter of Anderson-Braun at 50 cm distance from the source
yielded agreement within 5 % for 238pU and 252 Cf and within 14 %
for RaD-Be for the dose equivalent reading of the rem-counter
and the proportional counter.
3.3 Error Estimation
In the determination of the neutron dose rate via the counting
rate of the proportional counter the statistical error must be
considered above al 1 which is about 10 % for 10 min of measuring
- 8 -
Table 1: Counting Rate of the Proportional Cou~ter ~nd
Attenuation at 3 cm Tissue Depth
Free Air Phantom
Neutron Source Counting Ra te at 1 .25 cm + 3 cm Tissue
cpm % %
252 Cf 9550 100 ± 0,9 36.2
238pU 27. 1 100 ± 3 33
3R0079N 15. 3 100 ± 10 30
RaD-Be 280 100 ± 2 57
Table 2: Comparison of Nominal with Measured Neutron Flux Density
Neutron Flux Density at 1. 25 cm
Neutron n/cm 2 s Relative Reading
Source Emission Ra te Prop. Count. 1 Rem-Count. 2 Prop.Count. Rem-Count.
238pU 84 =84 79.5 100 % 100,5 %
252Cf 2.75 x 10 4 2. 96 x 10 4 2.98 x 10 4 107.5 % 11 4 %
244Cm 1.4 x 10 4 1. 74 x 10 4 1. 66 x 10 4 124 % 124,5 %
RaD-Be 799 870 754 109 % 100,5 %
1) reading at 1.25 distance from the source
2) calibration with Am-Be-neutrons; measured at 53 cm distance
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time. Other erroneous effects are produced by the assu~ption
of an identical 2 cm tissue depth for all patients. For example,
an increase of 0.5 cm in the tissue thickness and the detector-
source distance, respectively, entails a reduction of the neutron
dose by 7 % and 9 %, respectively. Individuel values of the
effective detector-source distance can be directly derived from
the results of an in-vivo gamma measurement. Referred to the
actual source distance, the gamma values measured at different
distances from the body surface follow a square law. However,
because of the differentattenuation of gamma rays and neutrons
in tissue, the source distance evaluated on patients can not be
transferred directly to the neutron measurement.
3.4 Measurement of the Neutron Emission Rate
The neutron emission rate is determined by comparison with a
238pU standard source S, using the same irradiation geometry
as in the in-vivo measurement (see Fig.5). NF(c) is the counting
rate in the free air at a distance c = 1.25 cm and Np(d) i:s the
counting rate obtained on a phantom with the source placed
at 2 cm tissue depth (d-c) and at a distance cl = 3.25 from
the 50urce. In an in-vivo measurement the neutron emission
rate is found to be
(cal ibration with standard source)
Q (in-vivo measurement)
\~e abtain a F = ( Q )NF(c) S neutronsin by free air calibrationcoun t
and(NF(C)) - 2.08 found fram the ratio of free air and phantom
Np(d) S-
counting rates of the proportional counter. The counting rate
of the proportional counter is determined by the geometrical
- 1 0 -
d e c re ase (k ), t heb ui 1du pan d at te nu a t ion i n t iss ue. Ther e f 0 r e
a
the counting rate in an in-vivo measurement is expressed by the
equation
(2)
3.5 Measurement of the Neutron Flux Density
Using formula (1) and (2) the neutron flux density at the
distance x from the center of the neutron source under free
air conditions is given by
<PF(x)
Q
=
a F N (d)P
4nx 2 k b(g)
a
-ag
e
(4 )
It is of special interest to estimate the neutron flux density
on the su~face of the pacemaker aS the maximum value in the
body of the patient and the neutron flux densityon the body
surface. In an in-vivo measurement the neutron flux density
for a given distance x from the source is determined from the
counting rate Np(d) on the patient, taking into account the
f r e e air c al i brat ion 0 f t he proport ion a I counter after f 0 r mu I a
(2) and (3)
,f-. () b( ) -a(x-c),f-. ( )~T x = x-c e ~F x
a F N (d) b(x-c) -a(x-c-g)
<PT(x) = p e
4nx 2 k b (g)
a
<P T (x)
a F Np (d)
=
4nx 2 k
a
for x < d (5a)
for x >d (5b)
This yields for the flux density on the body surface with x=d
= = 0.695 Np(d)
- 1 1 -
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Fig.5: Measuring positions for the in-vivo measurement
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and for the flux density on the surface of the pacemaker with x=c
b (0 )
b(g) e- ag
=
b (0 )
where b(O) is practically the fractionof backscattering from the
body on the very surface of the pacemaker, i .e., at a distance of
1.25 cm from the source center at 2 cm tissue depth. Additional
measurements performed at the proportional counter with and without
phantom, res pe c ti v e I y, y i eId e d b ( 0) = 1. 1 ± O. 0 1. S i mi I a r res u I t s
were obtained from measurements with the rem-counter (see Fig.6).
These results agree wel I with the calculation of dose distribution
in the immed]ate vicinity of a 252Cf needle embedded in the tissue,
which were performed by Auxier et al [2J. At a distance of 1 cm
from the needle the neutron dose encountered differs by some 10 %
from the corresponding kerma value found under free air conditions.
However, at 0.5 cm in the tissue the dose has built up by 40 %.
The pacemaker however is not surrounded by body tissue at these
distances from the relatively thin disk source.
3.6 Estimation of the Dose Equivalent Rate
In a first approximation a fission neutron spectrum can be assumed
for a 238pU source. Measurements of the neutron energy distribution
of 238 PU02 sources reveal a peak at 2.3 MeV which is caused by
additional 18 0 (a,n) reactions [3, 4J. The corresponding fluence-
dose conversion factors fGr fission neutrons, for 2.5 MeV neutrons
and for Am-Se-neutrons .Clre listed in Table 3. Following computations
were made for the determination of the dose equivalent rate:
1. Fluence-kerma conversion factor for 2.5 MeV neutrons with
respect to the fluence assayed in the body on the surface
of the pacemaker as weIl cis a qual ity factor Q = 9.
2. Fluence-dose equivalent conversion factor for 2.5 MeV neutrons
according to the NCRP recommendation with respect to the
fluence encountered in free air.
Table 3; Fluence-Dose Conversion Factors
For Kerma For Absorbed Dose* For Dose Equivalent
cm 2 d H / Q rad cm
2 Q d H
2d Krad rem cm
2 MeV 3.0 x 10- 9 3.63 X 10- 9 8.8 3.19 x 10- 8 ANSI (1970) [6J
4.27 x 10- 9 9·3 3.96 X 10- 8 ICRP (1973) [5J
2,5 MeV 3.3 x 10- 9 3.85 X 10- 9 9 3.47 X 10- 8 NCRP (1971) [7J
4.35 x 10- 9 8 3.48 X 10- 8 ICRP (1964) [8J
238pu 3.04 x 10- 9 4.06 X 10- 9 9. 1 3.7 X 10- 8 Kluge et.al [9J
Am-Be 3.66 x 10- 9 4.66 X 10- 9 7.6 3.54 x 10- 8 Kluge et.al [4J
235 U(n,f) 2.69 x 10- 9 3.77 X 10- 9 9.52 3.59 x 10- 8 Kluge et.al [ 4J
252 Cf 2.81 X 10- 9 3.9 X 10- 9 Kluge et.al [9J
3.0 X 10- 9 Stone et.al [13J
*) Absorbed dose at a tissue depth characterized by the maximum dose equivalent
w
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Table 4: Calibration Factors forthe Proportional Counter
used for In-vivo Measurements of Neutrons
Countin~ rate of the proportional counter
Np cpm at,3.25 cm depth
Probability of detection
u F = 3.67 x 10
3 neutrons per count
Emission rate
Body surface
<PT = 0.695 Np
.
U = 0.0745 x Np
Surfa~e of pacemaker
<P T = 7. 10 x Np
6 = 0.76 x Np
mrem/h
mrem/h
- 1 5 -
3. Fluence~dose equivalent conversion factor for the 238 pU
spectrum measured according to Kluge and Zille with respect
to the fluence encountered in the free air.
The conservative calculation according to [2J and [3J is based
on the maximum absorbed dose or dose equivalent found in a 30 cm
thick slab of soft tissue with parallelly incident neutrons. This
means overestima.tion of the dose equivalent, since with a
implanted neutron point source the comparable dose attenuation
curve in the tissue decreases more rapidly at smal 1 distances
from the source than with a broad beam of parallelly incident
neutrons.
This is also confirmed by neutron isodose curves in tissue
calculated by Auxier et al [2J for a 252 Cf needle. The assumption
Q = 9 is equally conservative, since according to the ICRP-
recommendations the definition of Q is also based on the
maximum dose equivalent in a 30 cm thick slab of tissue [5J,
whereas, the dose equivalent close to the pacemaker is smal ler.
Calculation according to 1. yields a value of 5.6 mrem/h for
the dose equivalent rate on the surface of the pacemaker. In
comparison, a value higher by 6.5 % and 13 %, respectively, is
obtained using calculations 2. and 3.
Due to the low detection sensitivity for neutrons, direct
measurements of the dose equivalent rate by means of the rem-
counter was possible only with the reference source. Considering
the buildup and attenuation of neutrons in 2 cm of tissue (see
Fig.7) and the backsca~tered fraction of neutrons from the
phantom (see Fig.6) 0.89 times the free air value is found for
the dose equivalent on the surface of the body. In the case of
the proportional counter no buildup appears in the first tissue
layers which gives only 0.8 times the free air value. The dose
equivalent rate measured with the rem-counter is therefore
- 16 -
200r-------------------------~
ABSORBER
.- ·-- • SOURCE
....--7cm-~
REM- COUNTER
50
20
100~===:O.....--o RQ/O- Be - NEUTRONS
..~ ~----..-
-............ *""'o~
.~, ~
252CI _ NEUTRONS~~
~"--
....J
W
0:::
z
W
t-
<{
0:::
C)
Z
t-
Z
::>
o
u
765432
1Ol.....-__-J... ...I..-__........L ...J.....__----'L...-__.....,.L..__---J
o
T1SSUE EQUIVALENT LAYER IN CM
Fig~7: Attenuation in tissue .of the neutron counting rate
measured wi th. the rem-counter
Table 5: Measured Result of In-vivo Measurements
Neutron Measurement Surface of Pacemaker
. . .
Np (d) Q <1J D D 6 /Dn y n y
cpm 10 3 .!:!. n
5 cm 2 s mrem/h mrem/h
Patient A 8.4 1. 07 60 6.4 2. 45 2.5
B 6.0 0.76 43 4.55 2. 38 1 .9 1
c 6.5 o.83 46.5 4.95 2. 31 2. 14
D 6.4 o.81 46 4.9 2.23 2.2
E 8.7 1 .10 62 6.6 3. 19 2.07
F 6.3 o.80 45 4.8 2. 38 2.02
G 9·2 1. 16 66 7.0 2.83 2.38
Phantom with
3R 0079N 6.7 0.85 48 5 . 1 2.48 2. 11
Phantom with
238 pU capsule 13 1. 65 93 9.9 2.83 3.5
A - G 7.4 0.93 53±10 5.6±1 2.54±0.5 2.18±0.3
i I
-.....J
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Table 6: Comparison of Measured andNominal Neutron Emission Rates
Neutron Emission Rate
s-1
Q 1) Q
0
2 ) QM/ QM
0
A 1070
B 762 750 1. 0 15
c 825 750 1 • 1
D 812 750 1 ,08
E 1100
F 800 750 1 .075
G 1170
Phantom
3R0079 N 850 864.7 0.98
Phantom
238Pu-capsule 1650
A - G 940
1 ) in-vivo measurement usJng proportional counter
2) as specified by supplier
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higher by 11 % compared to the flux measurement according to 1.
This result is in good agreement with a higher value of 13 %
obtained in calculation 3., since in both ca ses approximatly
the same conversion factors are taken into consideration.
4. Total Exposure of the Patient
4.1 Results of In-vivo Measurements
The results of in-vivo measurements carried out with the
proportional counter are represented in Table 5 for seven patients.
Additional phantom measurements were also performed with a complete
pacemaker and the reference source ( 238 pU capsule). To convert the
neutron flux density into the dose equivalent rate the fluence-
kerma conversion factor of calculation 1 was used for 2.5 MeV
neutrons with Q = 9 giving a factor of 0.107 mrem/h per n/cm s.
Consequently, the average neutron doseequivalent rate on the
surface of the implanted pacemaker was 5.6 ± 1 mrem/h, the
respective value of gamma radiation 2.54 ± 0.5 mrem/h. The
neutron gamma dose ratio is 2.18 which is higher by about 60 %
for the 238pU reference capsule due to the higher neutron dose
fraction.
Bcsides errors of measurement (see 3.3) systematic errors must
be taken into account, above all with respect to the emission
rate of the 238pU reference source used, which was determined
spectroscopically to be 1.65 x 10 3 S-l [3J. Using the
Anderson-Braun rem-counter, the cal ibration of which is based
- 1
on an Am-Be standard yield a valuc of 1.66 x 10 3 s . Thus,
a ca1 ibration of the proportional counter with the Am-Be standard
instead of the 238pU reference sour ce gives a dose equiva1ent
rate which is 10vJer by 5 % (cf. also Tab1e 2).
4.2 Comparison with Other Measurements
The results of the in-vivo measurement show good agreement
with the resu1ts of phant6m measurements and with the in-
formation of the suppl ier about the neutron emission rate of
the individual nuclide batteries. Deviations are within the
error of measurement of 10 % (see Table 6).
Table 7: Comparison of Measured Results of Dose Equivalent Rate on the Surface
of the Pacemaker
.
" Dn 1) oy 1) . 1Emission Rate Distance Dn Dy Dtot )
n/s cm mrem/h mrem/h mrem/h
.
Mean of in-vivo measurement 940 1. 25 5.6 2. 54 5.6 2. 54 8. 14
3 R0079 N in Phantom 850 1 .25 5. 1 2.42 5.6 2.68 8.28
2 ROO18s in Phantom .cllJ ]16 1.3(11) 3.6 1.5 5. 15 2.3 7.45
Battelle-Northwest [llJ 1.35(y) max. 1. 77 2.7 7.85
252 Cf in Phantom [10J 1400 2 3 - 5.7 -
Gibson et.al [12J 700±70 2 2 - 5.15 2 ) 2.7 7.85
5.6 2) 2.7 8 .. 3
1) dose equivalent for 940 n/s on the surface of the pacemaker implanted at 1.25 cm distance
of the source
2) recal~ulated from emission rate using the same fluence-dose equivalent conversion factor
as for the other sources; phantom value higher than free air value
N
Cl
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The total burden of the patient by gamma rays and neutrons is
presented in Table 7 for the surface of the pacemaker. The
table includes the results of respective phantom measurements
with a 252Cf source [10J as wel I as results measured by
Battel le-Northwest [lJ on a Medtronic pacemaker and results
measured by Gibson et al [12J on an Engl ish pacemaker. The
. - 1
results were related to a source strength of 940s and
1.25 cm distance from the center of the 238pU source. So, the
maximum burden on the surface of the pacemaker implanted is
8.14 mrem/h and 71.5 rem/a, respectively. Considering the
random and systematic errors of measurement, the aqreement
±4 %is very good which was found for the results of in-vivo
measurement and those proposed by other authors. Differences
in the amount of 0.6 ppm 236pU found with the Medtronic
pacemaker by in-vivo measurement and of 0.26 ppm with that
of Battelle-Northwest do not produce an essential ly different
gamma dose rate, since these differences are compensated again
by different separation ages of 238 pU of one and two years,
respectively.
Table 8 shows additional dose equivalent rates to be anticipated
on the body surface and at 50 cm from it, respectively.
4.3 Long-term Radiation Burden
The 236Pu-fraction, via the thalium-208 decay product implies
an increase in the gamma dose rate following chemical separation
of 238 PU . Based on theoretical computations, an increase by a
factor of 2.6 of the gamma dose rate is expected for a pacemaker
containing 0.5 ppm 236pu after aperiod of ten years following
chemical separation (see Fig.8) [llJ. However, within the period
o to 10 years, the mean dose rate for neutrons and gamma rays
is increased by 20 % only for 0.5 ppm and by 7 % fo~ 0.26 ppm
236pU, related to the dose rate measured one year after the
chemical separation (see Table 9).
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Table 8: Personal Burden through Medtronic Pacemaker
In-vivo Measurement 1 Dose Equivalent Rate
j.lrem/h rem/a
-
- - -. .D D Dtot Dtotn y
Surface of Pacemaker
1.25,cm from the source 5600 2540 8140 71 .5
Body surface
3.25 cm from the source 550 340 890 7.8
Free air at 50 cm distance 2. 3 1.4 3. 7 0.032
1) mean value, related to 940 n/s- 1 neutron emission
rate 1-2 years after chemical separation
Table 9: Increase in the Mean Dose Equivalent Rate with
Different Per iods of Implantation of the Pacemaker
Mean Dose Rate
-
.
Period in
Dtot mrem /hyears
0.26 ppm 236 pU 0.5 ppm 236pU
after one yea r 1 8.3 8.3
,0 - 5 8.42 8.63
0 - 10 8.91 10.0
0 - 15 9 . 11 10.55
0 - 20 9.20 10 . 8
1) related to the value measured on pacemaker 3R0079N
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Fig.8: Increase in the gamma dose rate following chemical
separation for a 238pu pacemaker with 0.26 ppm and
0.5 ppm 2 36 pu
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A 236pU content of 0.6 ppm for the Medtronic pacemaker was
, ,
specified by the suppl ier. In-vivo measurements were carried
out approximately 1 - 2 years after chemical separation. This
implles that for the Medtr~nic pacemakers and ten years of
implantation an increase i~ th~ mean gamma dose rate from 8.3
to about 11 mrem/h is anticipated. This represents the maximum
tissue burdenen the surfa.ce of the pacemaker; By using the
direct measurement of the .~amma dose rate on the'patient the
long-term 20 % increase per annum can be verified.
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